Taking a look at our biggest winners and losers and taking some time to reflect
A Public Markets note, written by students, for students.
This will be our only write-up in biotech!
A member of our team just pitched KKR. Here is the pitch and his experience!
Talking about $GIS, $QSR, and $LULU... written with Paromartho Chaudhuri
We hold a price target of $304, implying an 18% Downside
I hold a price target of $304, implying an 18% Downside
